Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.24.1.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 7,807,579 $ 7,266,080
Investments 985,730 0
Other current assets 118,987 66,433
Total current assets 8,912,296 7,332,513
Operating lease right-of-use asset 0 12,646
Total assets 8,912,296 7,345,159
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,435,160 1,757,393
Total current liabilities and total liabilities 1,435,160 1,757,393
Commitments and contingencies (Note 8)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 17,484,175 and 14,904,497 shares issued and outstanding at March 31, 2024, and December 31, 2023, respectively 17,484 14,905
Additional paid-in capital 69,302,864 65,793,210
Accumulated other comprehensive income (loss) 4,231 (14,132)
Accumulated deficit (61,847,443) (60,206,217)
Total stockholders’ equity 7,477,136 5,587,766
Total liabilities and stockholders’ equity $ 8,912,296 $ 7,345,159